Leaps by Bayer
Corporate VCLeverkusen · Seed–Growth · 7 people tracked
Team · 7 people
from curated & public directories
What they invest in
from 28 of 29 portfolio companiesBiotech ×20Healthtech ×12AI & Machine Learning ×10Digital Health ×10Deep Tech ×9AgTech ×4Medical Devices ×4FoodTech ×2
HQs:United States×17Singapore×1
Investments · 29 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 42023 · 32022 · 12021 · 22019 · 22017 · 115 dated
Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.
AI & Machine LearningBiotechDeep TechBoston, US
Richard Young, Ph.D.(Director)Anthony Hyman, Ph.D.(Director)Tony Hyman(Scientific Co-founder)Rick Young(Scientific Co-founder)Elisabeth Leiderman(Executive Officer)inAmeet Nathwani, M.D.(Executive Officer, Director)in
Co-investorsARCH Venture PartnersEcoR1 CapitalSamsara BioCapital6 Dimensions CapitalGeneral CatalystInnovation Endeavors+5 more
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.
BiotechDeep TechHealthtechCambridge, US
Daniel J Mandell(Executive Officer, Director)Tracey Lodie(Executive Officer)Christopher Gregg(Director)
BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)
Co-investorsREDMILEDigitalis VenturesDreamers VCRising TideAtlas VentureInnovation Endeavors+1 more
Indapta Therapeutics develops an off-the-shelf, allogeneic FcRγ-deficient natural killer (g-NK) cell therapy derived from healthy donors to treat cancer and autoimmune diseases.
BiotechHealthtechHouston, US
Guy DiPierro(Chief Operating Officer & Co-Founder)inSungjin Kim(Scientific Founder)John Sunwoo(Scientific Founder)Mark Frohlich(Executive Officer, Director)Mark W. Frohlich(Chief Executive Officer)Stefanie Mandl-Cashman(Acting Chief Scientific Officer)
Co-investorsRA CapitalVertex Ventures HC
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Co-investorsVida VenturesFoothill VenturesIllumina VenturesMedical Excellence CapitalVivo CapitalARCH Venture Partners+1 more
Soufflé Therapeutics develops nucleic acid medicines that precisely target and deliver genetic therapeutics to specific cell types to treat disease.
AI & Machine LearningBiotechDeep Tech
Victor Kotelianski(Founder)Daniel Anderson(Founder)Robert Langer(Founder)Marino Zerial(Founder)Brad Pentelute(Founder)Amir Nashat(Chief Executive Officer)
Co-investorsBessemer Venture PartnersSafar PartnersVida Ventures
65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.
BiotechDeep TechSingapore, SG
BoardSteve Courtney(Expert in Residence)
Co-investorsLightstone VenturesClavystBio
Ada offers intelligent health technology, including a medical library of doctor-created, research-based information about conditions and symptoms to help people make informed health decisions.
AI & Machine LearningDigital HealthHealthtech
Co-investorsRed River WestSamsung Catalyst FundUrania Ventures10x FoundersBertelsmann InvestmentsVitruvian Partners
BiotechWatertown, US
Kathy Bergsteinsson(Executive Officer)Kathy Yi(Executive Officer)Joseph Knowles(Executive Officer, Director)
BoardLucio Iannone(Director)Arjun Goyal(Director)Jill DeSimone(Director)
Co-investorsVida Ventures
Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.
AgTechBiotechClimate Tech
Co-investorsCapria VenturesCavallo VenturesGermin8 VenturesSunna VenturesVoyager PartnersYamaha Motor Ventures+1 more
Apollo Agriculture provides small-scale farmers with farming inputs, financing, insurance, and training to help them run more profitable agribusinesses.
AgTechAI & Machine LearningFintechImpact & Social GoodOakland, US
Earl Joseph St. Sauver(Director)Eli John Pollak(Executive Officer, Director)Eli Pollak(Co-founder & CEO)inBenjamin Njenga(CCO & Co-Founder)inEarl St Sauver(Co-founder)
BoardSeth Todd Silverman(Director)
Co-investorsAccionAnthemis VentureCeniarthCommunitas Capital PartnersEndeavor CatalystEquator+5 more
Co-investorsAlta PartnersARCH Venture PartnersDC Investment PartnersLongwood FundNextech InvestPathway to Cures+6 more
Celea develops deupirfenidone, a pulmonary therapeutic targeting idiopathic pulmonary fibrosis in partnership with physicians and patient advocacy organizations.
BiotechHealthtechMedical Devices
Co-investorsRA CapitalPureTech Health
Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease.
AI & Machine LearningBiotechDigital HealthHealthtechLongevitySan Mateo, US
David Furman, PhD(Co-Founder & Chairman of the Scientific Advisory Board)Mark Davis, PhD(Co-Founder & Scientific Advisory Board Member)inWolfgang Daum(Executive Officer, Director)David Goldberg(CEO)inDavid Furman(Director)
BoardNaveen Krishnan(Director)
Co-investorsBetter Food VenturesJoyance PartnersPaladin Capital GroupSocial StartsAhren Innovation Capital
Fork & Good develops cultivated meat technology using a hydroponic system approach that integrates cell biology with farming principles to produce real meat from cells at scale.
BiotechDeep TechFoodTechNutley, US
Gabor Forgacs(Chief Scientific Officer and co-founder)Andras Forgacs(Partner and co-founder)Niya Sharma(Co-founder)Niyati Gupta(Executive Officer, Director)
BoardLauren Loktev(Director)
Co-investorsAIR CapitalCollaborative FundMindshift CapitalThe Venture CollectiveBBG VenturesStarlight Ventures+1 more
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsAir Street CapitalLux CapitalObvious VenturesAmgen Ventures
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.Solasta Ventures+2 more
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardAndrew Farquharson(Director)Jak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalHumboldtInCube Ventures+1 more
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.
BiotechMedical Devices
Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)
Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+3 more
Nava Benefits is a technology-enabled benefits brokerage that pairs benefits consultants with AI-powered tools to help HR teams manage employee health benefits with less administrative work and lower costs.
HealthtechHR TechInsurTech
Brandon Weber(Founder)in
Co-investorsAvid VenturesGlynn Capital ManagementHomebrewArchetypeRA Capital
NewLeaf develops PPFM (Pink-Pigmented Facultative Methylotroph) microbial technologies for agriculture, offering EPA-registered biofungicide and bioinsecticide products (TS601 and TS201) plus crop-specific biostimulants for growers of corn, soy, cotton, rice and other crops.
AgTechBiotechSt. Louis, US
Thomas Laurita(Executive Officer, Director)Michael McFatrich(Executive Officer)Desmond Jimenez(Executive Officer)inStephen Kahn(Executive Officer)Janne Kerovuo(Executive Officer)inDoug Bryant(Executive Officer)
Co-investorsPangaea Ventures Us Inc.S2G InvestmentsSABIC VenturesPangaea Ventures
NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor.
BiotechHealthtechAustin, US
Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)inIvan Cheung(Chief Executive Officer)inLeena Gandhi(Chief Medical Officer)inTatiana Novobrantseva(Chief Scientific Officer)inAxel Hoos(Director)
Co-investorsCatalio Capital Management, LPMPM BioImpactSanofi VenturesCatalio Capital ManagementInvusSixty Degree Capital
One.bio develops food products designed to provide beneficial molecular signals to support health and address chronic inflammatory disease.
BiotechFoodTechHealthtechWellness & Fitness
Matt Amicucci(Co-Founder & Chief Science Officer)Matt Barnard(Co-Founder & CEO)
Co-investorsAcre Venture PartnersAlpha EdisonBetter Ventures Central LlcCollaborative FundDoon CapitalE12 Venture Capital, Llc+4 more
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound enhancing agents) to deliver genetic payloads to targeted sites in a redosable manner.
BiotechDeep TechDigital Health
Kenneth Greenberg(Founder)in
Co-investorsARCH Venture PartnersSymBiosisUCB VenturesVida VenturesVivo Capital
AgTechEmeryville, US
Eric Davidson(Director)inTravis Bayer(Director)inPaul Beck(Executive Officer)inDave Vosburg(Executive Officer)Adam Litle(Executive Officer, Director)inDerek Norman(Director)
Co-investorsCavallo VenturesCultivian Sandbox VenturesS2G InvestmentsFall Line CapitalFootPrint CoalitionNorthpond Ventures+2 more
Summer Health provides text-based, on-demand pediatric care that connects parents with doctors within minutes for their children's non-scheduled health needs.
ConsumerDigital HealthHealthtech
Co-investors7wire VenturesCoalition OperatorsCorewell Health VenturesIngeborg InvestmentsLux CapitalSequoia Capital+5 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions to help people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtech
Co-investorsAlta PartnersThreshold VenturesAlly Bridge GroupGeneral CatalystGeodesic CapitalHuman Capital+2 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtechDenver, US
Glen Tullman(Founder & CEO)in
Co-investors7wire VenturesCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint VenturesHuman Capital+5 more
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.
AI & Machine LearningBiotechDigital HealthMountain View, US
Anat Binur(Executive Officer, Director)Yanay Ofran(Director)Judith Weiss Paltiel(PhD, VP Development)
BoardScott Brady(Director)Samir Kaul(Director)in
Co-investorsIsrael Biotech FundKhosla VenturesSanara CapitalWestern Technology InvestmentFall Line CapitalPeakBridge VC
Woebot Health builds chat-based AI wellness tools to provide mental health support to individuals and organizations.
AI & Machine LearningDigital HealthMental Health
Alison Darcy(Founder)in
Co-investorsJAZZ Venture PartnersOwl VenturesAI FundNew Enterprise Associates (NEA)Temasek
Portfolio news
latest coverage across their companiesWoebot · chiefhealthcareexecutive.com · Aug 15, 2026
SonoThera · fiercebiotech.com · Aug 12, 2026
Metagenomi · za.investing.com · Aug 11, 2026
Celea Therapeutics · kalkine.co.uk · Aug 10, 2026
Summer Health · mobihealthnews.com · Jul 29, 2026
NewLeaf Symbiotics · agropages.com · Jul 24, 2026
SonoThera · statnews.com · Jul 17, 2026
Frequently asked questions
- What stage does Leaps by Bayer invest at?
- Leaps by Bayer invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Leaps by Bayer focus on?
- Leaps by Bayer focuses on AgTech, Biotech, Healthtech.
- Where is Leaps by Bayer located?
- Leaps by Bayer is headquartered in Leverkusen, DE.
Co-investors · 16
ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.
Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
Agent Capital is a healthcare venture capital firm that invests in novel, differentiated therapeutics and treatments addressing unmet patient needs across all stages of development.
Paladin Capital Group invests in early stage and growth companies developing cyber, AI and deep technologies that address security and resilience needs for commercial and government customers.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.
The Column Group (TCG) is a venture capital firm focused on building and backing biotechnology companies, applying an edge-to-edge investment model centered on company formation with capacity for long-term private and public capital support.
M Ventures is the corporate venture arm of Merck KGaA based in Darmstadt, Germany, operating from offices in Amsterdam, the US, and Israel. The firm invests globally across early-stage companies and spin-offs in areas aligned with Merck's core business, taking active roles in portfolio company development.
Founder Collective is a seed and pre-seed stage venture capital firm that invests across sectors, describing itself as sector agnostic and anti-thematic.
IA Ventures is a venture capital firm that invests in early-stage software and frontier technology companies.
▶4 more co-investors
Cofounders CapitalInnova Memphis, Inc.Lever VCFulcrum Global Capital
Firms observed investing alongside Leaps by Bayer, from public investor directories. Shared companies are the overlap with Leaps by Bayer's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Rho is an investment firm founded in 1981 that backs inventors, entrepreneurs, and operators across all stages of company growth to build market-defining companies.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.